SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-20-025429
Filing Date
2020-11-13
Accepted
2020-11-13 08:05:28
Documents
57
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10016888_10q.htm 10-Q 797728
2 EXHIBIT 31.1 brhc10016888_ex31-1.htm EX-31.1 12192
3 EXHIBIT 31.2 brhc10016888_ex31-2.htm EX-31.2 12223
4 EXHIBIT 32.1 brhc10016888_ex32-1.htm EX-32.1 5023
5 EXHIBIT 32.2 brhc10016888_ex32-2.htm EX-32.2 4965
12 image00002.jpg GRAPHIC 26909
  Complete submission text file 0001140361-20-025429.txt   3952370

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pdsb-20200930.xml EX-101.INS 560581
7 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20200930.xsd EX-101.SCH 36654
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdsb-20200930_cal.xml EX-101.CAL 41155
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdsb-20200930_def.xml EX-101.DEF 149827
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20200930_lab.xml EX-101.LAB 561585
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20200930_pre.xml EX-101.PRE 296535
Mailing Address 25B VREELAND ROAD FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 201309211
SIC: 2834 Pharmaceutical Preparations